Il-6 binding molecules
US-2024158492-A1 · May 16, 2024 · US
IL-6
IL-6 · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/248 |
| Official title | {IL-6} |
| Display label | IL-6 |
| Total patents | 501 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 41 |
| 2016 | 45 |
| 2017 | 61 |
| 2018 | 66 |
| 2019 | 44 |
| 2020 | 45 |
| 2021 | 40 |
| 2022 | 42 |
| 2023 | 47 |
| 2024 | 37 |
| 2025 | 25 |
| 2026 | 8 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Modified polypeptides for bispecific antibody scaffolds
US-9527927-B2 · Dec 27, 2016 · US
Protein complexes for antigen binding and methods of use
US-9518132-B2 · Dec 13, 2016 · US
Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
US-2016311931-A1 · Oct 27, 2016 · US
Antagonists of IL-6 to prevent or treat thrombosis
US-9468676-B2 · Oct 18, 2016 · US
Antibodies with modified affinity to fcrn that promote antigen clearance
US-2016244526-A1 · Aug 25, 2016 · US
Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for autoimmune disease
US-9416197-B2 · Aug 16, 2016 · US
Method for producing polypeptide heteromultimer
US-2016229915-A1 · Aug 11, 2016 · US
Oncostatin m receptor antigen binding proteins
US-2016137739-A1 · May 19, 2016 · US
Dosing regimens using anti-il-6 antibodies for the treatment of rheumatoid and psoriatic arthritis
US-2016130340-A1 · May 12, 2016 · US
Anti-IL-6/IL-6R Antibodies and Methods of Use Thereof
US-2016130351-A1 · May 12, 2016 · US
Antagonists of il-6 to prevent or treat thrombosis
US-2016115228-A1 · Apr 28, 2016 · US
Method for the treatment of glomerulonephritis by administering an IL-6 antibody
US-9321837-B2 · Apr 26, 2016 · US
Method for promoting muscle regeneration by administering an antibody to the IL-6 receptor
US-9260516-B2 · Feb 16, 2016 · US
Blood-brain-barrier dual variable domain immunoglobulins and uses thereof
US-2016032000-A1 · Feb 4, 2016 · US
Methods of producing antibodies in yeast
US-2016024203-A1 · Jan 28, 2016 · US
Antagonists of IL-6 to raise albumin and/or lower CRIP
US-9241990-B2 · Jan 26, 2016 · US
Human Oncostatin M Antibodies and Methods of Use
US-2016009798-A1 · Jan 14, 2016 · US
Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies
US-9234034-B2 · Jan 12, 2016 · US
Anti-il-6 antibodies for the treatment of oral mucositis
US-2015368337-A1 · Dec 24, 2015 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/248?
- CPC C07K16/248 is the Cooperative Patent Classification code for “IL-6.”
- How many patents are filed under CPC C07K16/248 (IL-6)?
- Our database includes 501 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/248 growing?
- Publication counts under this code: 37 in 2024 vs 25 in 2025 (latest complete years).